Heron Therapeutics (HRTX) EBT Growth (1y) (2011 - 2026)
Heron Therapeutics (HRTX) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
13.34% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
-51.60% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-313.33% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
-79.57% |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
-230.18% |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
71.54% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Heron Therapeutics |
85.57 Mn |
55.60 Mn |
24.07 Mn |
-251.08% |
| Date | Value |
|---|
| Mar 31, 2026 |
-251.08% |
| Dec 31, 2025 |
-99.09% |
| Sep 30, 2025 |
8.19% |
| Jun 30, 2025 |
74.60% |
| Mar 31, 2025 |
165.74% |
| Dec 31, 2024 |
140.83% |
| Sep 30, 2024 |
82.12% |
| Jun 30, 2024 |
84.80% |
| Mar 31, 2024 |
85.49% |
| Dec 31, 2023 |
49.79% |
| Sep 30, 2023 |
40.48% |
| Jun 30, 2023 |
14.33% |
| Mar 31, 2023 |
47.45% |
| Dec 31, 2022 |
61.98% |
| Sep 30, 2022 |
19.00% |
| Jun 30, 2022 |
18.14% |
| Mar 31, 2022 |
-20.74% |
| Dec 31, 2021 |
12.66% |
| Sep 30, 2021 |
11.43% |
| Jun 30, 2021 |
-8.47% |
